Tandem Diabetes (TNDM) Tops Q4 EPS by 7c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus

Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 7c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 16.87 --0 (-0%)
Previous Close $16.87    52 Week High $12.48 
Open $16.87    52 Week Low $1.60 
Day High $16.87    P/E N/A 
Day Low $16.87    EPS $-6.33 
Volume 517